BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29343851)

  • 1. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
    Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
    Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
    Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
    Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
    Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
    RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
    Jeong K; Murphy JM; Ahn EE; Lim SS
    Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
    Su B; Chen X; Zhong C; Guo N; He J; Fan Y
    J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.
    Jung D; Khurana A; Roy D; Kalogera E; Bakkum-Gamez J; Chien J; Shridhar V
    Sci Rep; 2018 Feb; 8(1):2487. PubMed ID: 29410485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.
    Bryant P; Zheng Q; Pumiglia K
    Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
    Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
    Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of Skp2 and the tumor suppressor protein p27 in colorectal cancer.
    Vasile Bochis O; Achimas-Cadariu P; Vlad C; Fetica B; Corneliu Leucuta D; Ioan Busuioc C; Irimie A
    J BUON; 2017; 22(5):1122-1130. PubMed ID: 29135092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.